The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...

Aspirin is considered the cornerstone of secondary prevention of coronary artery disease. However, the evidence supporting aspirin was largely generated before the advent of modern pharmacological and ...

Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized ...

Assessing intermediate coronary lesions with an intracoronary pressure wire improves clinical outcomes in patients undergoing cardiac catheterization and percutaneous coronary intervention (PCI).

Coronary artery disease frequently accompanies severe aortic stenosis and is identified in up to half of patients referred for transcatheter aortic valve implantation (TAVI).1 Yet the optimal ...

We hypothesized that percutaneous coronary intervention (PCI) preceded by early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI) or with abciximab alone ...

Heart failure hospitalisation significantly increases mortality after PCI. Learn why adverse events should not be treated ...

PCI reduces angina frequency in stable coronary artery disease regardless of age, with older patients deriving the greatest ...

Please provide your email address to receive an email when new articles are posted on . PCI without surgery on-site is as safe as PCI at centers with on-site surgery across randomized controlled ...

A statewide effort to get hospitals in Michigan to lower their procedural radiation levels for PCI resulted in a steady decrease over a 6-year period, new data show. “We were really pleased to see ...